CV Sciences Statistics

Total Valuation

CV Sciences has a market cap or net worth of $8.16 million. The enterprise value is $7.77 million.

Market Cap	8.16M
Enterprise Value	7.77M

Important Dates

The last earnings date was Monday, August 14, 2023, before market open.

Earnings Date	Aug 14, 2023
Ex-Dividend Date	n/a

Share Statistics

CV Sciences has 163.23 million shares outstanding. The number of shares has increased by 7.21% in one year.

Shares Outstanding	163.23M
Shares Change (YoY)	+7.21%
Shares Change (QoQ)	+0.86%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	0.00%
Float	163.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	15.63
PS Ratio	0.51
Forward PS	n/a
PB Ratio	3.46
P/FCF Ratio	10.74
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.49
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	10.23

Financial Position

The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.12.

Current Ratio	1.23
Quick Ratio	0.20
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	0.36
Interest Coverage	9.40

Financial Efficiency

Return on equity (ROE) is -136.83% and return on invested capital (ROIC) is -101.33%.

Return on Equity (ROE)	-136.83%
Return on Assets (ROA)	-38.18%
Return on Capital (ROIC)	-101.33%
Revenue Per Employee	$377,571
Profits Per Employee	-$76,952
Employee Count	42
Asset Turnover	1.44
Inventory Turnover	1.42

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.76% in the last 52 weeks. The beta is 0.60, so CV Sciences's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+23.76%
50-Day Moving Average	0.06
200-Day Moving Average	0.04
Relative Strength Index (RSI)	49.11
Average Volume (20 Days)	421,524

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CV Sciences had revenue of $15.86 million and -$3.23 million in losses. Loss per share was -$0.02.

Revenue	15.86M
Gross Profit	7.16M
Operating Income	-2.67M
Pretax Income	-3.23M
Net Income	-3.23M
EBITDA	-2.43M
EBIT	-2.67M
Loss Per Share	-$0.02

Full Income Statement

Balance Sheet

The company has $662,000 in cash and $274,000 in debt, giving a net cash position of $388,000 or $0.00 per share.

Cash & Cash Equivalents	662,000
Total Debt	274,000
Net Cash	388,000
Net Cash Per Share	$0.00
Equity (Book Value)	2.36M
Book Value Per Share	0.01
Working Capital	1.39M

Full Balance Sheet

Cash Flow

Operating Cash Flow	760,000
Capital Expenditures	n/a
Free Cash Flow	760,000
FCF Per Share	$0.00

Full Cash Flow Statement

Margins

Gross margin is 45.13%, with operating and profit margins of -16.84% and -20.38%.

Gross Margin	45.13%
Operating Margin	-16.84%
Pretax Margin	-20.38%
Profit Margin	-20.38%
EBITDA Margin	-15.34%
EBIT Margin	-16.84%
FCF Margin	4.79%

Dividends & Yields

CV Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.21%
Shareholder Yield	-7.21%
Earnings Yield	-39.60%
FCF Yield	9.31%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CV Sciences has an Altman Z-Score of -12.26 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-12.26
Piotroski F-Score	5